Name | Recombinant Human Nidogen-1/Entactin Protein, CF |
---|---|
Supplier | R&D Systems |
Catalog | 2570-ND |
Category | Protein |
Prices | $329.00 |
Sizes | 50 µg |
Species Reactivities | Human |
Nature | Recombinant |
Source | Mouse myeloma cell line, NS0-derived Leu29-Lys1114 (Gln1113Arg), with an N-terminal 9-His tag |
Purity | >95%, by SDS-PAGE under reducing conditions and visualized by silver stain |
Bioactivity | Measured by the ability of the immobilized protein to support the adhesion of SVEC4‑10 mouse vascular endothelial cells. When 4 x 10 4 cells/well are added to rhNidogen-1 coated plates (30 µg/mL with 100 µL/well), approximately 40-75% will adhere after one hour at 37 °C. Optimal dilutions should be determined by each laboratory for each application. |
Endotoxin | <1.0 EU per 1 μg of the protein by the LAL method. |
SwissProt/Accession | AAH45606 |
Gene | NID1 |
Sequence | His |
Supplier Page | Shop |
Willumsen N, Bager CL, Leeming DJ, Bay-Jensen AC, Karsdal MA. Neoplasia. 2017 Apr;19(4):271-278.
Toda M, Ueno M, Yamada J, Hiraga A, Tanaka H, Schlotzer-Schrehardt U, Sotozono C, Kinoshita S, Hamuro J. Invest Ophthalmol Vis Sci. 2016 Sep 1;57(11):4599-605. doi:
Mattsson JM, Ravela S, Hekim C, Jonsson M, Malm J, Narvanen A, Stenman UH, Koistinen H. PLoS One. 2014 Sep 19;9(9):e107819.
Zhang H, Tasnim F, Ying JY, Zink D. Biomaterials. 2009 May;30(15):2899-911.
Hendrickx AP, van Luit-Asbroek M, Schapendonk CM, van Wamel WJ, Braat JC, Wijnands LM, Bonten MJ, Willems RJ. Infect Immun. 2009 Nov;77(11):5097-106.